Literature DB >> 18815866

Rapid genotyping of tumor necrosis factor alpha with fluorogenic hybridization probes on the LightCycler.

Naoko Hayashi1, Yu Imamura, Yukiharu Hiyoshi, Hiroshi Takamori, Toru Beppu, Masahiko Hirota, Hideo Baba.   

Abstract

Genotyping of tumor necrosis factor alpha (TNF-alpha) has become an important procedure in the selection of high-risk population of septic shock and prevention from death due to septic shock. We present a single-tube method for TNF-alpha genotyping that performed on the LightCycler by melting curve analysis with allele-specific fluorescent probe. A fragment covering the polymorphic site is amplified in the presence of two fluorescently labeled hybridization probes. During amplification, probe hybridization is observed as fluorescence increases every cycle as the product accumulates during amplification. A single base mismatch resulted in a melting temperature (Tm) shift of 7-8 degrees C, allowing for the easy distinction of a common type allele from the polymorphic allele. Using this method, genotyping of 104 samples was completed within 1 h without the need for any post-PCR sample manipulation, thereby eliminating the risks of end-product contamination and sample tracking errors. The genotypes determined with the LightCycler were identical when compared with a conventional sequencing. The simplicity, speed, and accuracy of real-time PCR analysis using FRET probes make it the method of choice in the clinical laboratory for genotyping of a variety of human DNA polymorphisms and mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815866     DOI: 10.1007/s10238-008-0009-x

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  22 in total

1.  Rapid genotyping of human platelet antigen 1 (HPA-1) with fluorophore-labelled hybridization probes on the LightCycler.

Authors:  M S Nauck; H Gierens; M A Nauck; W März; H Wieland
Journal:  Br J Haematol       Date:  1999-06       Impact factor: 6.998

Review 2.  DNA probes: applications of the principles of nucleic acid hybridization.

Authors:  J G Wetmur
Journal:  Crit Rev Biochem Mol Biol       Date:  1991       Impact factor: 8.250

3.  Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid.

Authors:  D J Conway; M J Holland; R L Bailey; A E Campbell; O S Mahdi; R Jennings; E Mbena; D C Mabey
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR.

Authors:  M J Lay; C T Wittwer
Journal:  Clin Chem       Date:  1997-12       Impact factor: 8.327

5.  Haplotyping of TNFalpha gene promoter using melting temperature analysis: detection of a novel -856(G/A) mutation.

Authors:  Y Song; J Araki; L Zhang; T Froehlich; M Sawabe; T Arai; T Shirasawa; M Muramatsu
Journal:  Tissue Antigens       Date:  2005-10

6.  Identification and characterization of a novel repressor site in the human tumor necrosis factor alpha gene.

Authors:  C L Fong; A H Siddiqui; D F Mark
Journal:  Nucleic Acids Res       Date:  1994-03-25       Impact factor: 16.971

7.  Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese.

Authors:  T Higuchi; N Seki; S Kamizono; A Yamada; A Kimura; H Kato; K Itoh
Journal:  Tissue Antigens       Date:  1998-06

8.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

9.  Functional analysis of a new polymorphism in the human TNF alpha gene promoter.

Authors:  F Pociot; S D'Alfonso; S Compasso; R Scorza; P M Richiardi
Journal:  Scand J Immunol       Date:  1995-10       Impact factor: 3.487

10.  An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.

Authors:  A G Wilson; N de Vries; F Pociot; F S di Giovine; L B van der Putte; G W Duff
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.